Key Players in the Vascular Stents Market Adopted Product Launch & Product Enhancements as their Key Growth Strategy

Medtronic, plc (Ireland), Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK SE & Co. KG (Germany), B. Braun Melsungen AG (Germany), Terumo Corporation (Japan), STENTYS SA (France), MicroPort Scientific Corporation (China), Meril Life Sciences Pvt. Ltd. (India), Vascular Concepts (India), W. L. Gore and Associates (U.S.), C. R. Bard (U.S.), Endologix, Inc. (U.S.), Lombard Medical Technologies (U.K.), Translumina GmbH (Germany), and JOTEC GmbH (Germany) are the major players in the vascular stents market. Product launch and product enhancements were the key strategies adopted by players operating in this market.

View more detailed TOC @

http://www.marketsandmarkets.com/Market-Reports/vascular-stent-market-199869009.html

Other players in this market include OrbusNeich (Hong Kong), Aachen Resonance GmbH (Germany), amg International GmbH (Germany), Arterial Remodeling Technologies (France), Bioabsorbable Therapeutics, Inc. (U.S.), Biosensors International Group, Ltd. (Singapore), Devax, Inc. (U.S.), Elixir Medical Corporation (U.S.), S & G Biotech (South Korea), InSitu Technologies Inc. (U.S.), Braile Biomédica (Brazil), Grinm Advanced Materials Co., Ltd. (China), Cook Medical (U.S.), Lifetech Scientific (Shenzhen) Co., Ltd. (China),  Eurocor GmbH (Germany), Fortimedix B.V (Netherlands), InspireMD (U.S.), Medinol Ltd. (Israel), Micell Technologies, Inc. (U.S.), Reva Medical, Inc. (U.S.), Sahajanand Medical Technologies Pvt. Ltd. (India), TriReme Medical Inc. (U.S.), Tryton Medical, Inc. (U.S.), eucatech AG (Germany), ICON Medical Corp. (U.S.), and XTENT, Inc. (U.S.).

Abbott Laboratories (U.S.) is the leading player in the vascular stents market. The company offers a robust product portfolio and has a strong geographic presence. Abbott focuses on continuous product development to maintain its leading position in the vascular stents market. For instance, in May 2015, the company received CE Mark for its Absorb GT1, a fully dissolving stent system. In March 2014, the U.S. FDA approved its Supera Peripheral Stent System.

Medtronic plc (Ireland) is one of the leading players in the vascular stents market. The company’s leading position can be attributed to its strong product portfolio and brand identity in the vascular stents market. The company mainly focuses on product launches and expansion to sustain its growth in the vascular stents market. Some of the recent products launched by the company include the EverFlex Self-expanding Peripheral Stent with Entrust Delivery System (July 2015) and Resolute Onyx Drug-Eluting Stent (DES) (November 2014).

Request for Free Sample Report @ https://www.marketsandmarkets.com/requestsample.asp?id=199869009 

Companies are focusing on adopting organic and inorganic growth strategies to synergistically develop advanced products in the market. These strategies help market players to strengthen their product offerings, cater to the unmet needs of customers, increase their profitability, and expand their presence in the global market.

The overall growth strategies mapped from 2014 to 2017 include product approvals; product launches and enhancements; partnerships, collaborations, and contracts; expansions; acquisitions; and other developments such as certifications. Approvals, product launches, and enhancements accounted for the largest share of the overall strategic developments mapped in the above-mentioned period. Medtronic plc (Ireland), Abbott Laboratories (U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK SE & Co. KG (Germany), B. Braun Melsungen AG (Germany), TERUMO CORPORATION (Japan), STENTYS SA (France), and MicroPort Scientific Corporation (China) are the companies that majorly adopted these strategies.